Dodge; Jeffrey Alan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dodge; Jeffrey Alan.The latest application filed is for "selective estrogen receptor modulators for the treatment of vasomotor symptoms".

Company Profile

0.14.15

Dodge; Jeffrey Alan - Indianapolis IN US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective estrogen receptor modulator for the treatment of osteoarthritis Grant 8,476,300 - Dodge , et al. July 2, 2	2013-07-02
Selective estrogen receptor modulators for the treatment of vasomotor symptoms Grant 8,217,032 - Dally , et al. July 10, 2	2012-07-10
Selective Estrogen Receptor Modulators For The Treatment Of Vasomotor Symptoms App 20110281847 - Dally; Robert Dean ; et al.	2011-11-17
Selective Estrogen Receptor Modulator for the Treatment of Osteoarthritis App 20110166182 - Dodge; Jeffrey Alan ; et al.	2011-07-07
Selective estrogen receptor modulators containing a phenylsulfonyl group Grant 7,585,977 - Dally , et al. September 8, 2	2009-09-08
Indole Sulfonamide Modulators of Progesterone Receptors App 20090069400 - Bleisch; Thomas John ; et al.	2009-03-12
Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms App 20090023917 - Dally; Robert Dean ; et al.	2009-01-22
Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators Grant 7,462,647 - Dodge , et al. December 9, 2	2008-12-09
Selective Estrogen Receptor Modulators App 20080227814 - Dodge; Jeffrey Alan ; et al.	2008-09-18
Selective Estrogen Receptor Modulators App 20080221163 - Dodge; Jeffrey Alan ; et al.	2008-09-11
Selective Estrogen Receptor Modulators Containing A Phenylsulfonyl Group App 20080214612 - Dally; Robert Dean ; et al.	2008-09-04
Selective estrogen receptor modulators App 20070111988 - Dally; Robert Dean ; et al.	2007-05-17
Substituted benzopyrans as selective estrogen receptor-beta agonists Grant 7,217,734 - Dodge , et al. May 15, 2	2007-05-15
Selective estrogen receptor modulators App 20070066595 - Dodge; Jeffrey Alan ; et al.	2007-03-22
Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators App 20070054956 - Dodge; Jeffrey Alan ; et al.	2007-03-08
Substituted dipeptides as growth hormone secretagogues Grant 7,125,840 - Dodge , et al. October 24, 2	2006-10-24
Selective estrogen receptor modulators containing a phenylsulfonyl group App 20060183736 - Dally; Robert Dean ; et al.	2006-08-17
Growth hormone secretagogues Grant 6,992,097 - Hauser , et al. January 31, 2	2006-01-31
Growth hormone secretagogues App 20050143318 - Dodge, Jeffrey Alan ; et al.	2005-06-30
Substituted benzopyrans as selective estrogen receptor-beta agonists App 20040249167 - Dodge, Jeffrey Alan ; et al.	2004-12-09
Growth hormone secretagogues Grant 6,828,331 - Dodge , et al. December 7, 2	2004-12-07
Growth Hormone secretagogues App 20040122234 - Hauser, Kenneth Lee ; et al.	2004-06-24
Substituted dipeptides as growth hormone secretagogues App 20040058971 - Dodge, Jeffrey Alan ; et al.	2004-03-25
Growth hormone secretagogues Grant 6,639,076 - Hauser , et al. October 28, 2	2003-10-28
Substituted benzopyrans as selective estrogen receptor .beta. agonists Grant 6,630,508 - Dodge , et al. October 7, 2	2003-10-07
Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration Grant 6,096,764 - Bryant , et al. August 1, 2	2000-08-01
Benzothiophenes for treating estrogen deficiency Grant 6,060,488 - Dodge , et al. May 9, 2	2000-05-09
2-acylaminopropanamides as growth hormone secretagogues Grant 5,773,441 - Hipskind , et al. June 30, 1	1998-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.